Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% potassium hydroxide solution versus cryotherapy for genital warts
IRCT20230417057941N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of potassium hydroxide in anogenital warts (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Number of lesions, Time to complete recovery and 6 more. Started May 2023; status: completed.
02
Drugs
potassium hydroxide
03
Conditions
anogenital warts
Beyond the preview
Go deeper on IRCT20230417057941N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230417057941N1.